Disease / condition

Acute Myeloid Leukemia clinical trials

Free access to 644 studies·10+ countries·Updated daily171 recruiting
644
Total trials
10+
Countries
10+
Sponsors
171
Recruiting
By phase
N/A180
Phase 2154
Phase 1127
Phase 366
Early Phase 163
By status
Completed212
Recruiting171
Not yet recruit...79
Unknown71
Terminated51
Top countries
United States of America179
China98
France52
Germany36
Italy17
Top sponsors
The First Affiliat...13
University of Ulm9
Massachusetts Gene...9
Gruppo Italiano Ma...9
Assistance Publiqu...9
Recent trials
Latest clinical trials for Acute Myeloid Leukemia
2017-003434-87
Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma.
Cincinnati Children's Hospital...
NCT06389292·Phase 3Not yet recr...
A Pivotal Phase 3 Study of APG-2575 (Lisaftoclax) Combined With Azacytidine in the Treatment of Acute Myeloid Leukemia
Ascentage Pharma Group Inc.China
NCT06379360·Phase 2Recruiting
Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid Leukemia (AML) Patients
The First Affiliated Hospital ...China
NCT06387069·Phase 3Not yet recr...
A Study to Evaluate HMPL-306 in Patients With IDH1- and IDH2-mutated Acute Myeloid Leukemia
Hutchmed
NCT06370000·Phase 4Not yet recr...
Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality
Virginia Commonwealth Universi...United States of America
NCT06351306·Phase 2Recruiting
DEC-C and Thioguanine for R/R AML
Joseph JurcicUnited States of America
NCT06349239Recruiting
Oral Azacitidine Maintenance Post-CPX 351
Centre Hospitalier Universitai...France
NCT06328179Recruiting
Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA.
Huai'an First People's Hospita...China
NCT06317649·Phase 2Not yet recr...
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
National Cancer Institute (NCI...
NCT06323590Recruiting
Refining the Role of Mid-induction Bone Marrow Biopsy in Acute Myeloid Leukemia: A Pilot Study
University of Alabama at Birmi...United States of America
NCT06301425Not yet recr...
MRD Response-adapted Allo-HSCT for Adverse-risk AML
Peking University People's Hos...
NCT06297551Recruiting
Acute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)
Suhu LiuUnited States of America
NCT06295029Not yet recr...
Personalized Medication Software for BCL-2 Inhibitor in AML Patients Using Machine Learning and Genomics
The Affiliated Nanjing Drum To...
NCT06285890·Phase 1Not yet recr...
Phase I Study of HC-7366 With Azacitidine and Venetoclax for Acute Myeloid Leukemia
M.D. Anderson Cancer CenterUnited States of America
NCT06284486·Phase 2Not yet recr...
A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib
M.D. Anderson Cancer CenterUnited States of America
NCT06279572Recruiting
Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy
Mayo ClinicUnited States of America
NCT06232694Recruiting
Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML
The First Affiliated Hospital ...China
NCT06234904·Phase 1Not yet recr...
Study of IBR733 Cell Injection in Acute Myeloid Leukemia
Imbioray (Hangzhou) Biomedicin...China
NCT06232655·Phase 2Not yet recr...
Cladribine Venetoclax in Monocytic AML
University of Colorado, DenverUnited States of America
NCT06220162·Phase 2Recruiting
VAC Regimen for AML Patients Who Failed to Response to VA Regimen
The First Affiliated Hospital ...China
About this record

Access comprehensive clinical trial information for Acute Myeloid Leukemia through Pure Global AI's free database. This collection includes 644 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 171 trials are actively recruiting participants.

Research for Acute Myeloid Leukemia is being conducted in United States of America, China, France and 7+ other countries. Leading sponsors include The First Affiliated Hospital of Soochow University and University of Ulm. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 644 clinical trials studying Acute Myeloid Leukemia, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include The First Affiliated Hospital of Soochow University, University of Ulm, Massachusetts General Hospital, among others.